InvestorsHub Logo
Followers 9
Posts 750
Boards Moderated 0
Alias Born 10/19/2008

Re: Echo20 post# 84500

Thursday, 03/13/2014 12:17:53 PM

Thursday, March 13, 2014 12:17:53 PM

Post# of 146240
I think they are more postulates based on an understanding of typical and potential physiological responses. The in-vivo (within and actual living organism) test were done on KM mice.

I can't seem to copy links well anymore, the one paper title is:

Nanotoxicity comparison of four amphiphilic polymeric micelles with similar hydrophilic or hydrophobic structure - Oct 3, 2013, which states:

When these in vitro (on cells) and in vivo (on mice) results were compared comprehensively, we found that the toxicity in vivo was not as significant as that in vitro. There are several possible reasons: (1) The micelles in vivo exist mainly in the blood system, which is a dynamic environment, whereas the in vitro studies are performed in a relatively static environment,

I think there are some humna phase testing beginning for delivering cancer fighting compounds, but I am unclear on that or status of.

Again, I must caution, I am pushing the limits of my contemporary knowledge to allow me to keep it all in proper context. Addtionally, other activities are preventing me from delving extremely deep into the various on-going research efforts being made by many investigators.

My biggest concern is not the toxicity, but that other investigators and groups are exploring this area for anti-virals, and while Diwan and others have patents, I know form experienc ein other areas that if someone with deep pockets wants to do something, patents dont always prevent it. First successful human trials is most important! Thus my previous statements about taking too much time.

Good luck to all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News